1. Home
  2. KGS vs PTGX Comparison

KGS vs PTGX Comparison

Compare KGS & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kodiak Gas Services Inc.

KGS

Kodiak Gas Services Inc.

N/A

Current Price

$67.43

Market Cap

6.7B

Sector

N/A

ML Signal

N/A

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

N/A

Current Price

$95.54

Market Cap

6.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KGS
PTGX
Founded
2011
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
6.4B
IPO Year
2023
2016

Fundamental Metrics

Financial Performance
Metric
KGS
PTGX
Price
$67.43
$95.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
13
Target Price
$57.17
$108.23
AVG Volume (30 Days)
2.0M
478.7K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
2.93%
N/A
EPS Growth
58.93
N/A
EPS
0.20
0.05
Revenue
$1,308,100,000.00
N/A
Revenue This Year
$12.30
$874.25
Revenue Next Year
$7.96
N/A
P/E Ratio
$336.75
$1,908.20
Revenue Growth
12.83
N/A
52 Week Low
$30.06
$49.86
52 Week High
$77.68
$107.84

Technical Indicators

Market Signals
Indicator
KGS
PTGX
Relative Strength Index (RSI) 45.81 44.46
Support Level $33.80 $90.58
Resistance Level $77.18 $98.27
Average True Range (ATR) 2.26 3.49
MACD -1.16 -0.69
Stochastic Oscillator 22.40 30.28

Price Performance

Historical Comparison
KGS
PTGX

About KGS Kodiak Gas Services Inc.

Kodiak Gas Services Inc is an operator of contract compression infrastructure in the United States. The company manages its business through two operating segments: Contract Services and Other Services. Contract Services consists of operating company-owned and customer-owned compression, gas treating, and cooling infrastructure, pursuant to fixed-revenue contracts to enable the production and gathering of natural gas and oil. Other Services consist of a full range of contract services to support the ancillary needs of customers, including station construction, maintenance and overhaul, freight and crane charges, and other time and material-based offerings. Maximum revenue for the company is generated from its Contract Services segment.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: